Arkolith/Insider Trading/IOVA/Form 4

Graf Finckenstein Friedrich

Chief Medical OfficerIOVANCE BIOTHERAPEUTICS, INC. (IOVA) · full profile →Form 4 · filed Mar 4, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Tax withholding(F)7K$3.79$27K117K
Mar 2, 2026Option exercise(M)13K—$0124K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2026Option exercise(M)9K—$035K
Mar 2, 2026Option exercise(M)4K—$00

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-023535) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML